US4333734A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Diagnostic device for fecal occult blood and method of use
Assignee: Memorial Sloan Kettering Cancer Center
•
Filing: 1980-10-08
•
Granted: 1982-06-08
•
Expires: 2000-10-08
Abstract
Abstract Diagnostic test device for fecal occult blood utilizing a test matrix such as paper impregnated with guaiac. False-positive results in the presence of peroxidases are prevented by adding to the matrix a compound that cleaves protein hydrogen bonds such as guanidine hydrochloride and a chelating agent that binds calcium and/or magnesium such as EDTA.
Inventors
- 👤 Martin Fleisher
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 18:25
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/725; C; C12; C12Q; C12Q1/00; C12Q1/26; C12Q1/28; C12Q2326/00
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
93 words
In a process for determining the presence of fecal occult blood in a test sample using a test matrix containing guaiac, the improvement for preventing false-positive results in the presence of peroxidase enzymes comprising the steps of at least partially denaturing the protein forming the peroxidase enzymes with an effective amount of a compound from the group consisting of soluble salts of guanidine, urea and salicyclic acid to attenuate enzymatic activity; and effectively removing from reaction with the peroxidase enzymes, magnesium and/or calcium ions, necessary for efficient biochemical activity of the peroxidase enzyme.
Claim 2
Dependent Claim
93 words
In a process for determining the presence of fecal occult blood in a test sample using a test matrix containing guaiac, the improvement for preventing false-positive results in the presence of peroxidase enzymes comprising the steps of at least partially denaturing the protein forming the peroxidase enzymes with an effective amount of a compound from the group consisting of soluble salts of guanidine, urea and salicyclic acid to attenuate enzymatic activity; and effectively removing from reaction with the peroxidase enzymes, magnesium and/or calcium ions, necessary for efficient biochemical activity of the peroxidase enzyme.
Claim 3
Dependent Claim
25 words
The process of claim 1 wherein the ions are effectively removed from reaction with the peroxidase enzymes with an effective amount of a chelating agent.
Claim 4
Dependent Claim
11 words
The process of claim 2 wherein the test matrix is paper.
Claim 5
Dependent Claim
15 words
The process of claim 2 wherein the chelating agent is selected from EDTA and EGTA.
Claim 6
Dependent Claim
29 words
The process of claim 4 further comprising the steps of adding the compound and the chelating agent to the matrix and thereafter supporting the test sample on the matrix.
Claim 7
Dependent Claim
28 words
The process of claim 4 further comprising the steps of adding the test sample to the matrix and thereafter adding the compound and chelating agent to the matrix.
Claim 8
Dependent Claim
98 words
In a test kit for the process of claim 1, the improvement comprising a solution for application to the test matrix in a predetermined unit volume and containing an effective amount, per predetermined unit volume, of (a) a compound from the group consisting of soluble salts of guanidine, urea and salicyclic acid that cleaves protein hydrogen bonds, to at least partially denature peroxidase enzymes in the test sample and (b) of a chelating agent that binds calcium and magnesium ions to insure the effective removal of calcium and magnesium from reaction with peroxidase enzymes in the test sample.
Claim 9
Dependent Claim
13 words
Test kit of claim 7 wherein the chelating agent is EDTA or EGTA.
Claim 10
Dependent Claim
11 words
Test kit of claim 7 wherein the test matrix is paper.
Claim 11
Dependent Claim
88 words
Diagnostic test device for false-positive test free testing for fecal occult blood in the presence of interfering peroxidase enzyme, in accordance with the process of claim 1, comprising a test matrix of paper impregnated with an effective amount of guaiac, a compound from the group consisting of soluble salts of guanidine, urea and salicyclic acid that cleaves protein hydrogen bonds thereby to denature the protein forming the enzyme, and a chelating agent that binds calcium and/or magnesium ions thereby to remove the ions from reaction with the enzyme.
Claim 12
Dependent Claim
20 words
The device of claim 10 wherein said compound is a soluble salt of guanidine and said chelating agent is EDTA.
Claim 13
Dependent Claim
20 words
The test device of claim 10 wherein there is present about 0.25 millimoles EDTA and about 0.15 millimoles guanidine hydrochloride.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-06-07 | 1985-12-07 | 1986-06-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-06-07 | 1989-12-07 | 1990-06-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-06-07 | 1993-12-07 | 1994-06-08 | $7700.00 | Window Closed / Lapsed |